Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

New Zelboraf data shows big survival boost
Fierce Pharma
Friday, February 24, 2012 - 11:25am
tags:
Zelboraf, melanoma, Roche
How to Trade Dendreon Ahead of Earnings, and Other Biotechs to Watch
Minyanville
Friday, February 24, 2012 - 10:02am
tags:
earnings, Dendreon, Agenus, Galena Biopharma, ImmunoCellular
Roche seen extending Illumina offer at same price
Reuters
Friday, February 24, 2012 - 10:01am
tags:
Roche, Illumina, M&A
How Qnexa's Positive Panel Review Generated Alpha For Short Sellers
Seeking Alpha
Friday, February 24, 2012 - 9:59am
tags:
Qnexa, Vivus, obesity, Arena Pharmaceuticals, Orexigen
PDL BioPharma's CEO Discusses Q4 2011 Results - Earnings Call Transcript
Seeking Alpha
Friday, February 24, 2012 - 9:57am
tags:
PDL Biopharma, earnings
Buy, Sell, or Hold: Keryx Pharmaceuticals
Motley Fool
Friday, February 24, 2012 - 9:56am
tags:
Keryx, colorectal cancer, Zerenex, perifosine, kidney failure
Endo Pharmaceuticals Reports Strong Fourth Quarter Financial Results; Provides 2012 Financial Guidance
Yahoo
Friday, February 24, 2012 - 9:55am
tags:
Endo, earnings
Warner Chilcott sees restructuring complete in 2012, to impact 500 employees
Yahoo/Fly on the Wall
Friday, February 24, 2012 - 9:54am
tags:
Warner Chilcott, restructuring, layoffs
Who Would Have Ever Thought A Vaccine To Protect Babies' Brains Could Be A Tough Sell?
Forbes
Friday, February 24, 2012 - 9:52am
tags:
vaccines, Novartis, Menveo, Bexsero, meningococcal disease
J.&J.’s Next Chief Is Steeped in Sales Culture
NY Times, NY
Friday, February 24, 2012 - 9:50am
tags:
JNJ, Pharma CEOs, Alex Gorsky
FDA panel recommends Chelsea Therapeutics drug
Reuters
Thursday, February 23, 2012 - 5:49pm
tags:
FDA, advisory panels, Chelsea Therapeutics, Northera
U.S. panel backs Forest Labs drug for smoker's cough
Reuters
Thursday, February 23, 2012 - 5:45pm
tags:
Forest Labs, COPD, Almirall, aclidinium bromide
An Overview Of 4 Drug Manufacturers Yielding Over 4%
Seeking Alpha
Thursday, February 23, 2012 - 5:43pm
tags:
Eli Lilly, Merck, Pfizer, Bristol-Myers Squibb
Drug Companies Feel Price Pressure
NY Times, NY
Thursday, February 23, 2012 - 5:43pm
tags:
drug pricing
J&J Recall: Manufacturing issues believed behind CEO departure
Fierce Pharma Manufacturing
Thursday, February 23, 2012 - 12:04pm
tags:
recalls, JNJ, William Weldon, Pharma CEOs
MannKind Narrows Loss
Yahoo/Zacks
Thursday, February 23, 2012 - 11:59am
tags:
earnings, MannKind
The Battle For The Anti-Coagulation Market
Seeking Alpha
Thursday, February 23, 2012 - 11:58am
tags:
anticoagulants, Pfizer, Sanofi, Bristol-Myers Squibb
Chelsea Therapeutics: FDA Panel Live Blog
TheStreet.com
Thursday, February 23, 2012 - 10:43am
tags:
FDA, advisory panels, Chelsea Therapeutics, Northera
4 Compelling Alternatives To Vertex Pharma
Seeking Alpha
Thursday, February 23, 2012 - 10:42am
tags:
Vertex Pharmaceuticals, Acorda, Aveo Pharmaceutical, Jazz Pharmaceuticals, Momenta
Vivus rockets 99% on FDA nod
Marketwatch
Thursday, February 23, 2012 - 10:41am
tags:
FDA, Vivus, obesity, Qnexa

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.